The Board of ERIS Lifesciences has approved the appointment of Rajeev Dalal (DIN : 00222650) as an gAdditional Director (Non]Executive Independent Director)h on the Board of Directors of the Company with effect from 19 December 2020 for a term of 5 (five) years upto 18 December 2025, subject to approval of the Shareholders of the Company. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader, Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.